1 December 2013 in Food Chemistry
16 September 2016 in PLOS Pathogens
Human adenoviruses (HAdVs) are nonenveloped proteinaceous particles containing a linear double-stranded DNA genome. HAdVs cause a spectrum of pathologies in all populations regardless of health standards. Following repeat exposure to multiple HAdV types, we develop robust and long-lived humoral and cellular immune responses that provide life-long protection from de novo infections and persistent HAdV. How HAdVs, anti-HAdV antibodies and antigen presenting cells (APCs) interact to influence infection is still incompletely understood. In our study, we used physical, pharmacological, biochemical, fluorescence and electron microscopy, molecular and cell biology approaches to dissect the impact of immune-complexed HAdV (IC-HAdV) on human monocyte-derived dendritic cells (MoDCs). We show that IC-HAdV generate stabilized complexes of ~200 nm that are efficiently internalized by, and aggregate in, MoDCs. By comparing IC-HAdV, IC-empty capsid, IC-Ad2ts1 (a HAdV-C2 impaired in endosomal escape due to a mutation that impacts protease encapsidation) and IC-AdL40Q (a HAdV-C5 impaired in endosomal escape due to a mutation in protein VI), we demonstrate that protein VI-dependent endosomal escape is required for the HAdV genome to engage the DNA pattern recognition receptor AIM2 (absent in melanoma 2). AIM2 engagement induces pyroptotic MoDC death via ASC (apoptosis-associated speck protein containing a caspase activation/recruitment domain) aggregation, inflammasome formation, caspase 1 activation, and IL-1β and gasdermin D (GSDMD) cleavage. Our study provides mechanistic insight into how humoral immunity initiates an innate immune response to HAdV-C5 in human professional APCs. While numerous studies have addressed the response to primary virus infections, we know relatively little about the interplay between recurrent and/or persistent infections and the memory humoral immune response on professional antigen-presenting cells. Immune complexed-adenoviruses are present in patients suffering from adenoviremia. In addition to the impact of HAdV infections on healthy and immune suppressed hosts, humoral immunity hampers the use of human adenovirus vectors during gene transfer. Our study shows that anti-adenovirus humoral immunity engages an innate immune response to cause pyroptosis of antigen-presenting cells. The downstream effects of this cells death is unknown and may impact the stimulation and differentiation of T cells into an inflammatory phenotype that may be associated with the complications during adenovirus disease and adenovirus vector use. Our study generates insight into how humoral immunity shapes the response to adenoviruses in healthy and immune-compromised individuals, during human adenovirus-based vaccine use, and during antibody therapy.
1 July 2012 in Food and Chemical Toxicology
1 May 2018 in International Journal of Pharmaceutics
1 August 2019 in Acta Biomaterialia
1 October 2014 in Toxicology and Applied Pharmacology